Taishi Yamamoto
Overview
Explore the profile of Taishi Yamamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamada Y, Kobayashi R, Yamamoto T, Fujii H, Iihara H, Hiroko K, et al.
J Pharm Health Care Sci
. 2024 Apr;
10(1):19.
PMID: 38671535
Background: Medication errors related to the pre-admission medication history obtained on admission are a major cause of medication error during hospitalization. Medication reconciliation (MR) improves patient safety through the detection...
2.
Yamada Y, Niwa T, Ono Y, Yamada S, Niwa K, Yasue M, et al.
J Antimicrob Chemother
. 2023 Oct;
78(12):2933-2937.
PMID: 37889089
Objectives: Although use of AUC-guided vancomycin dosing was recommended in the revised 2020 consensus guideline, collection of multiple vancomycin serum samples to calculate AUC may cause clinical complications. AUC calculated...
3.
Sada M, Matsushima S, Ikeda M, Ikeda S, Okabe K, Ishikita A, et al.
JACC Basic Transl Sci
. 2023 Sep;
8(8):992-1007.
PMID: 37719427
Doxorubicin (DOX)-induced cardiomyopathy has poor prognosis, and myocardial inflammation is intimately involved in its pathophysiology. The role of invariant natural killer T (iNKT) cells has not been fully determined in...
4.
Shiraishi C, Matsumoto A, Ichihara K, Yamamoto T, Yokoyama T, Mizoo T, et al.
Nat Commun
. 2023 Apr;
14(1):2131.
PMID: 37080962
Although several ribosomal protein paralogs are expressed in a tissue-specific manner, how these proteins affect translation and why they are required only in certain tissues have remained unclear. Here we...
5.
Enzan N, Matsushima S, Ikeda S, Okabe K, Ishikita A, Yamamoto T, et al.
Circ Res
. 2023 Mar;
132(9):1110-1126.
PMID: 36974722
Background: Mitochondrial DNA (mtDNA)-induced myocardial inflammation is intimately involved in cardiac remodeling. ZBP1 (Z-DNA binding protein 1) is a pattern recognition receptor positively regulating inflammation in response to mtDNA in...
6.
Miyamoto H, Ikeda M, Ide T, Tadokoro T, Furusawa S, Abe K, et al.
JACC Basic Transl Sci
. 2022 Sep;
7(8):800-819.
PMID: 36061338
Ischemia-reperfusion (I/R) injury is a promising therapeutic target to improve clinical outcomes after acute myocardial infarction. Ferroptosis, triggered by iron overload and excessive lipid peroxides, is reportedly involved in I/R...
7.
Niwa T, Yasue M, Harada S, Yamada Y, Otsubo M, Yamada M, et al.
J Infect Chemother
. 2022 Apr;
28(7):923-928.
PMID: 35379525
Introduction: While the revised 2020 consensus guideline recommends the use of area under the concentration-time curve (AUC)-guided vancomycin monitoring, collecting multiple vancomycin serum samples to calculate the AUC may cause...
8.
Ishikita A, Matsushima S, Ikeda S, Okabe K, Nishimura R, Tadokoro T, et al.
iScience
. 2021 Dec;
24(12):103517.
PMID: 34934932
Molecular mechanisms mediating cardiac hypertrophy by glucose metabolism are incompletely understood. Hexosamine biosynthesis pathway (HBP), an accessory pathway of glycolysis, is known to be involved in the attachment of O-linked...
9.
Okabe K, Matsushima S, Ikeda S, Ikeda M, Ishikita A, Tadokoro T, et al.
Hypertension
. 2020 Mar;
75(4):991-1001.
PMID: 32160098
Nox4 (NADPH [Nicotinamide adenine dinucleotide phosphate] oxidase 4) is a major source of oxidative stress and is intimately involved in cardiac hypertrophy. DPP (Dipeptidyl peptidase)-4 inhibitor has been reported to...
10.
Ikeda S, Matsushima S, Okabe K, Ikeda M, Ishikita A, Tadokoro T, et al.
Sci Rep
. 2019 Jul;
9(1):9850.
PMID: 31285514
Ca/calmodulin-dependent protein kinase II (CaMKII) and nuclear factor-kappa B (NF-κB) play crucial roles in pathogenesis of doxorubicin (DOX)-induced cardiomyopathy. Their activities are regulated by intracellular Ca. We hypothesized that blockade...